000 01909 a2200505 4500
005 20250516182451.0
264 0 _c20140717
008 201407s 0 0 eng d
022 _a1476-4598
024 7 _a10.1186/1476-4598-12-147
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaraswati, Sarita
245 0 0 _aα-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
_h[electronic resource]
260 _bMolecular cancer
_cNov 2013
300 _a147 p.
_bdigital
500 _aPublication Type: Journal Article; Retracted Publication
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHuman Umbilical Vein Endothelial Cells
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Docking Simulation
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeovascularization, Pathologic
_xdrug therapy
650 0 4 _aPolycyclic Sesquiterpenes
650 0 4 _aProstate
_xmetabolism
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aProto-Oncogene Proteins c-akt
_xgenetics
650 0 4 _aRats
650 0 4 _aSesquiterpenes
_xpharmacology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aVascular Endothelial Growth Factor Receptor-2
_xantagonists & inhibitors
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aKumar, Shakti
700 1 _aAlhaider, Abdulqader A
773 0 _tMolecular cancer
_gvol. 12
_gp. 147
856 4 0 _uhttps://doi.org/10.1186/1476-4598-12-147
_zAvailable from publisher's website
999 _c23294137
_d23294137